Visine, also known as Vispring, is a brand of eye drops produced by Kenvue.[1] Visine was first introduced in 1958 and was acquired by Pfizer in 1999.[2][3] In 2006, Johnson & Johnson acquired Visine, along with Pfizer's entire consumer healthcare portfolio.[4] The original formulation of Visine includes the active ingredient tetrahydrozoline hydrochloride, which is a vasoconstrictor that constricts the eye's superficial blood vessels to temporarily reduce eye redness.[5]